Dave Alderman, Molekule Consulting
Dave Alderman, President, Molekule Consulting
David Alderman is President of Molekule Consulting (“Molekule”), a global competitive intelligence and management consultancy headquartered in Miami, Florida. Molekule partners with pharmaceutical, biotechnology and medical device companies providing evidence-based solutions and actionable strategic and tactical insights. Aligning intelligence outcomes and focusing results thereby enabling our client partners — blue chip pharmaceutical and biotechnology players — to win in the highly dynamic and competitive biopharmaceutical universe, Molekule supports seminal biopharmaceutical business objectives. We leverage a continuum of tactical and strategic decisions for pharmaceutical, biotechnology and medical device clients via informed, pragmatic and meaningful competitive intelligence & consulting solutions.
David’s core strength is in partnering with biopharmaceutical clients to develop actionable strategies and critical insights driving business development, sustainable growth, overall strategy and transformational gains for Molekule’s client partners.
David is recognized as a Therapy Area Leader (“TAL”) with an in-depth understanding of multiple disease states, current and future market players, and developmental pipeline compounds in multiple markets and therapeutic areas.
David’s efforts have helped pharmaceutical and biotech companies grow revenues, profits and market share in highly competitive and emerging markets, resulting in a high level of client satisfaction and retention.
Matthias Borst, Becton Dickinson GmbH
Matthias Borst, Global Vice President Commercial Excellence Diabetes Care, Becton Dickinson GmbH
Matthias Borst is Global Vice President Commercial Excellence Diabetes Care at Becton Dickinson GmbH. Matthias has held this position since 2016. Prior to that he was Vice – President / General Manager Europe & EMA BD Medical Diabetes Care. Since 2005, he has been a Member of the Board of Directors of the German Trade Association for the Diagnostic Industry (VDGH)/ He has served as Chairman of the Board since 2010.
Eva Maria Bossong, Merck & Co.
Eva Maria Bossong, Head Integrated Insights Europe, Merck & Co.
Karin Busse, Grunenthal
Karin Busse, Associate Director Marketing – Project Lead New Pain Brand Launch, Grunenthal
Nicola Cowland, Cello Health Insight
Nicola Cowland, CEO, Cello Health Insight
Joint CEO of Cello Health Insight with extensive agency, client-side and consultancy experience. Combines leading the business with an active interest in developing collaborative working partnerships with clients to design research that answers complex business questions. Responsible for various people initiatives across Cello Group plc, including the Cello Academy and Cello Partnership schemes.
Dennis Engelke, Jazz Pharmaceuticals
Dennis Engelke, Director, Business Analysis & Insight, Jazz Pharmaceuticals
Since joining Jazz Pharmaceuticals in 2015, Dennis has been working in the International Portfolio Planning team responsible for the analysis and monitoring of the current Haematology and Oncology business by providing commercial insights which meaningfully improve brand strategies across the International region. In addition, he is assessing development assets or acquisition targets, contributing towards the final Go/No-Go decision. He is working in close collaboration with the commercial, medical, and business development leadership teams ensuring identification of insights, transfer of best practice and a holistic assessment of new product targets.
Dennis has 10 years of hands-on experience in the innovative and generic pharmaceutical industry and held previously global strategic marketing, business development and business intelligence positions for Specialty Pharmaceuticals at Actelion Pharmaceuticals and Fresenius Kabi.
He holds a Master degree in Business and Economics from the Universities of Hamburg (Germany) and Uppsala (Sweden).
Vikas Hiremath, Biogen
Vikas Hiremath, EU+ Strategic Insights and Analytics, Interferons Lead, Biogen
Vikas Hiremath is the interferon analytics lead for the Europe and Canada region at Biogen. His experience has been primarily focused in the areas of forecasting, sales force size and structure, portfolio and disease area strategy, and dynamic modeling in the pharmaceutical industry. Prior to Biogen, Vikas worked at ZS, a management consulting firm, with a focus on analytically driven approaches to sales and marketing issues. He holds an MSE in Chemical Engineering and Applied Chemistry from Columbia University and a BSE in Chemical Engineering from the University of Michigan.
Adriënne Hoevers, SKIM
Adriënne Hoevers, Senior Research Manager, SKIM
Adriënne is Senior Research Manager in the Healthcare team based in Rotterdam, Netherlands. She has over 10 years of experience in both national as international healthcare market research. Adriënne has experience across a wide array of research techniques spanning qualitative and quantitative objectives, based on a deep knowledge of many indications areas. Adriënne gained a specific interest in biologics and biosimilars by working on challenging business questions in the area of oncology, auto immune diseases and cardiovascular diseases. Adriënne has a talent for simplifying complex healthcare topics and uses this talent to make the research results actionable to her clients.
Adriënne holds a Master of Science degree (MSc) in International Business Communication (graduated in 2004) from Radboud University Nijmegen.
Katrin Hoffmann, UCB
Katrin Hoffmann, Head of Marketing Strategy, Senior Director, UCB
Katrin Hoffman is the Head of Marketing Strategy, Senior Director at UCB. Katrin was previously the Global Commercial Insights Lead Gastrointestinal/Internal Medicine Business Unit at Shire Pharmaceuticals. Prior to Shire, Katrin was a Strategic Marketing & Sales consultant at ZS Associates. Katrin has 10+ years of experience in the Health Care industry with a strong focus on commercial excellence. Katrin holds a Master degree of Psychology with minor subject in Business administration from the University of Mannheim. She received the “High Potential Award 2004” by the DGFP and the Haufe Media Group for Top 10 Master thesis.
Claus Kremoser, Phenex Pharmaceuticals AG
Claus Kremoser, General Manager, Phenex Pharmaceuticals AG
Claus Kremoser studied biochemistry at the universities of Tübingen and Munich from 1986 – 1992 before he performed his PhD work in the group of the outstanding neurobiologist Friedrich Bonhoeffer at the Max-Planck-Institute for Developmental Biology in Tübingen from 1992 – 1996. Part of this work was published in “Cell” and “EMBO Journal”.
Jemma Lampkin, AkzoNobel
Jemma Lampkin, Segment Manager, Aerospace Coatings, AkzoNobel
Jemma Lampkin coordinates the global marketing intelligence function for the Specialty Coatings strategic marketing unit at AkzoNobel. Specialty Coatings is a division of the Performance Coatings business area and specializes in surface protection solutions for the yacht, automotive, aerospace and consumer electronic markets. Jemma has 10 years of experience in the market research industry and has managed hundreds of market research studies during her career within a multitude of industries, including pharmaceuticals, medical devices, fast moving consumer goods, telecom, etc. Prior to AkzoNobel, she worked for international market research consultancies SKIM and Investment Technology Group. She holds a Bachelor’s degree in Psychology from Columbia University in New York City.
Christine Launay, Actelion Pharmaceuticals
Christine Launay, Director, Global Commercial Insights, Actelion Pharmaceuticals, Ltd.
Christine is Director Global Commercial Insights at Actelion, a leading biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical needs. She is passionate about driving functional excellence, as well as about providing strategic and tactical insights ultimately guiding business decisions. With over 15 years of experience in Global Marketing Research roles within a mix of blue chip (Novartis, Bayer DC) & start up (Galderma, Biogen) healthcare companies, she enjoys leveraging innovative marketing research approaches to uncover deep understanding of customers and markets dynamics at different stages of the development of a product or a brand. Christine holds a Maitrise ès Sciences de Gestion from Paris-Dauphine University and a DESS in Marketing from the IAE of Aix-en-Provence. Also, she has been an active member of the HBA where she served as Europe Vice-President in 2013, and as first Europe Research Director in 2012.
Dr. Petra Leiding, Teva Berlin
Dr. Petra Leiding, Head of Business Analytics, Teva Berlin
After her Ph.D. in Biochemistry at the Max Planck Institute Petra started in market research. Petra was working for 10 years on the MR agency side, first with focus on FMCGs and later on she built up a specialized pharma team while also finishing her MBA. Since 2010 Petra was able to enrich her pharma expertise during her work at AstraZeneca as Business Intelligence Manager and finally as a Director of Reimbursement Analysis. Since October 2015 she is leading the Teva Ratiopharm Business Analytics team in Germany.
Davide Maiello, Knauf Insulation
Davide Maiello, Head of Market & Business Intelligence for Europe & CIS, Knauf Insulation
Davide Maiello is an Italian national with a Master in Applied Economics and Statistics from University of Naples (IT) and Ecole de Commerce Solvay in Brussels (BE). He started the carrier in marketing specializing in marketing intelligence and analytics for the online channels at the European HQ for Staples, where he worked for 7 years. Afterwards, Davide lead the Marketing Analytics group for Accenture in Benelux between 2005 and 2008. Since 2008, Davide has filled the role of Head of Market & Business Intelligence for Europe & CIS at Knauf Insulation, driving international market research, customer insight and market forecast.
Steve Martino, M Health
Steve Martino, Co-Managing Partner, M Health
Steve is an award-winning advertising writer and creative director with 30 years of experience in helping marketers recognize opportunities, define strategies and build integrated campaigns in several industries. He began his career at consumer ad agencies working on CPG and automotive accounts. Since 2001 he has been working with global biopharma and healthcare clients. Steve combines a deep understanding of strategy with a highly creative vision.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Susan McDonald, Naxion
Susan McDonald, President & CEO, Naxion
As CEO of NAXION, and leader of the firm’s Healthcare practice, Susan is a marketing strategist whose areas of expertise include demand forecasting and product optimization, pricing, market segmentation, brand positioning and portfolio strategy. She is known for her marketing ingenuity and her track record in guiding commercialization of paradigm-changing technologies that require new market models, including some of the industry’s most important global brands. Other sectors in which she has extensive experience include OTC pharmaceuticals and consumer products – both packaged goods and technology-driven categories.
Susan holds M.A. and Ph.D. degrees from the Annenberg School for Communication, University of Pennsylvania, where she was trained in communications theory and social psychology. Her B.A. was awarded magna cum laude, Phi Beta Kappa, from Smith College.
Guy Murray, MSD
Guy Murray, Director, Market Research & Analytics, MSD
Guy has worked in the pharmaceutical industry for over 15 years within various Business Intelligence functions in country, regional and global roles. Guy has a keen interest in quantitative market research & analytics including the development and use of Big Data, Real World Data and Public Access Data for market research. In his current role Guy leads the Market Research & Analytics Compliance and Operations Team within the Global Market Research and Analytics function.
Daniel Pascheles, Molekule Consulting
Daniel Pascheles, CEO, Molekule Consulting
Dr. Daniel R. Pascheles is CEO of Molekule Consulting. Pascheles was formerly Head of Global Intelligence at Merck & Co., Inc., which he joined early 2005 from Aventis Inc. where he was Vice President and head of Corporate Competitive Intelligence. He has worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for 14 years in various positions and locations.
Pascheles studied Pharmacy at the Swiss Federal Institute of Technology in Zurich, Switzerland. He received his Ph.D. in Pharmaceutical Technology from the same university. He has done additional study at the University of Kansas in Lawrence, Kansas.
Pascheles is Past-President and current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also member of the Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES).
Andrea Pecci, Takeda Italia S.p.A.
Andrea Pecci, Business Insight & Commercial Excellence Lead, Takeda Italia S.p.A.
Andrea Pecci has more the 20 years experience focusing in CRM, market research, market trends and forecasting, sales and marketing excellence, competitive intelligence, sales force effectiveness and insight. Driven by innovation, Andrea built up the first real CRM Cloud based more than 10 years ago.
He is now developing concrete tactics to include Digital and Multichannel into pharma business activity.
Lottie Pollak, GlaxoSmithKline
Lottie Pollak, Head of Global Market Research, GlaxoSmithKline
Lottie has worked in pharmaceutical market research for much of the last 30 years. For most of the last decade she has been at GSK where she is now Head of Global Market Research. She is also a patient who has experienced some of the products and services that our industry provides. From this base she is keen to make sure that we look widely, are open to new ideas and use everything at our disposal to bring together insights that help drive better decision making for companies, healthcare systems, practitioners and patients.
Michael Pröschel, Vifor Pharma
Michael Pröschel, Head of Northern Europe and General Manager, Vifor Pharma
Michael is the Head of the Northern European Region and General Manager Germany for Vifor Pharma (www.viforpharma.com). He has over 20 years of hands-on experience in general management, sales, marketing and clinical research in the pharmaceutical industry, both in international and national functions – including hospital and retail brands. He is and has been a member of various strategic working groups within the companies he has been working for.
Rafaat Rahmani, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics
Rafaat Rahmani is the president and founder of Lifescience Dynamics Ltd., with 24 years’ experience of working with the world’s leading companies in the USA, Europe, Middle East and Asia. His area of specialist knowledge includes competitive intelligence, strategic market research, forecasting, market access, pricing & reimbursements, marketing, and strategy.
He has experience in both industry and consulting such as various marketing roles in industry and with professional services, leading and delivering major competitive intelligence and consulting assignments for the top 20 pharmaceutical companies. He has helped organisations with a variety of strategic and operational issues.
Prior to starting Lifescience Dynamics he was working with a specialist healthcare consultancy leading their consulting practice where he worked on many varied life science and healthcare consultancy assignments over a seven year period. Previously he worked for Eli Lilly in Finance, MR CI, Portfolio, Marketing,CNS Business Unit and Strategy roles. In addition, he has a strong background in FMCG marketing with Pepsi-Cola, McDonalds and general management in UAE. He has an MBA from Manchester Business School, UK, and a BBA from the University of Houston, USA.
Frank Schröder, Vifor Fresenius Medical Care Renal Pharma
Frank Schröder, Head, Global Market Insights & Business Analytics, Vifor Fresenius Medical Care Renal Pharma
Frank has worked in the field of market research and business analysis for 15 years. Having started at the agency side, he moved to the pharmaceutical industry for the second part of his career. Currently Frank is heading the Global Market Insights and & Business Analytics department for the Joint Venture of Vifor Pharma and Fresenius Medical Care. In his current role he oversees the generation of all market insights, competitive intelligence, business analytics and forecasting for the Nephrology related business. Furthermore he takes the lead in all launch related insight projects to support and consult on marketing strategy. In his free time Frank enjoys sport of any kind and is a big fan of Sword & Sorcery literature.
John Surie, M Health
John Surie, Customer Insight Director, M Health
John is a strategic brand planner and customer insight specialist with 20 years experience in the development of insight-led international brand positioning and communications concepts. He brings a deeper, more insightful understanding of patient, healthcare provider and payer mind states and attitudes, rooted in an in-depth knowledge of the key global healthcare markets.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Susanne West, Teva Pharmaceuticals
Susanne West, Head of European Market Intelligence, Teva Pharmaceuticals Europe
Susanne is the Head of Customer and Market Insights (CMI) at Teva Pharmaceuticals Europe (TPE). Susanne and her team enable faster and better decision making by the delivering actionable insights and recommendations based on innovative market research, connecting business and brand strategy to planning and forecasting, and uncovering deep and differentiating market and customer insights.
Susanne joined TPE from Ipsos Healthcare where she was a Senior Director before relocating to the Netherlands in May 2014. Prior to this, Susanne spent 5 years at Kantar Health where she held senior strategic and development roles, and headed up a research team providing innovative market research solutions to the pharmaceutical industry. Susanne has accumulated 15 years of research experience from positions with A+A, Datamonitor and Decision Resources.
Susanne holds a Ph.D. in Pharmacy Practice and Pharmacoeconomics, as well as first honours degrees in Chemistry and Pharmacy. This academic background led Susanne to hold post-doctoral and lecturing posts in a number of Universities where key interests included evaluation of pharmaceutical services for various patient groups, compliance to medication and patient access to drug therapies.
Xander Wiewel, Elanco
Xander Wiewel, Global Customer Insights Leader, Elanco
Xander is managing the market research teams in Europe. Recently Canada and Australia have been added to his responsibilities. His team is active in all major European countries and is responsible for providing actionable insights to the business units. In his previous position at Lilly Xander was leading the Neuroscience business unit in the Netherlands and was a member of the Dutch management team. In his first years at Lilly Xander was responsible for sales force operations and market research for the European mid-size countries. Recently the focus of the market research team shifted to better understanding customer loyalty and how to improve the customer experience. Before joining Lilly Xander worked for IMS Health with a special focus on consultancy. Xander graduated from the Amsterdam University with a MSc in business economics. Outside of the office Xander loves to spend time with family and friends and tries to go to the gym.